The 13D Report
The 13D Report
Shareholder activism
⌘K
Signup free
activistletters

STAAR Surgical (STAA): Broadwood Partners Urges Shareholders to Reject Alcon Merger Over Governance and Valuation Concerns

Summary

Broadwood Partners’ presentation argues that STAAR Surgical’s sale to Alcon is ill-timed, flawed, and undervalued. It claims STAAR’s issues—mainly temporary weakness in China—are easing, with growth and profitability expected to rebound in 2026. The board allegedly ran a rushed, single-bidder process favoring Alcon, ignoring other interested parties and approving a $28-per-share offer that’s 55% below Alcon’s 2024 bid. Broadwood also highlights conflicts of interest and management’s financial incentives, urging shareholders to reject the merger and back a full strategic review to realize STAAR’s long-term value

Company Name: STAAR Surgical Company
Symbol: STAA
Filing Date: Oct-02-2025
Filer Name: Broadwood Partners L.P.

Download Presentation
Broadwood-Oct-02-2025.pdf
10 MB
download-circle

Source:

https://www.sec.gov/Archives/edgar/data/718937/000121390025095514/ea0259891-dfan14a_broadwood.pdf

Member discussion

More like this

Khrom Capital Pushes Acadia Healthcare (ACHC) Board to Pursue Sale, Slams Entrenched Leadership and Poor Capital Allocation

Summary Khrom Capital, owning 5.5% of Acadia Healthcare, criticized the company’s decade-long underperformance, poor capital allocation, and entrenched

STAAR Surgical (STAA): Broadwood Capital Urges Shareholders to Reject Alcon Merger, Highlighting Governance Conflicts and Poor Timing

Summary Broadwood Capital, owning 27.5% of STAAR Surgical, urged shareholders to vote against the proposed $28-per-share sale to Alcon,

Al Hartman Presses Silver Star Properties REIT (SLVS) Holders: Reject Current Board, Back Liquidation Plan Amid Alleged Misconduct and Value Destruction

Summary Al Hartman’s Hartman Shareholder Alliance urges Silver Star investors to vote the BLUE proxy as a “last chance”

Broadwood Partners Challenges STAAR Surgical (STAA) Sale to Alcon, Citing Inopportune Timing, Governance Issues, and Undervaluation

Summary Broadwood Partners, STAAR Surgical’s largest shareholder with a 27.5% stake, urged stockholders to vote against the proposed

Yunqi Capital Challenges STAAR Surgical (STAA)–Alcon Deal, Citing Undervaluation, Weak China Outlook Assumptions, and Governance Failures

Summary Yunqi Capital, a 5.1% shareholder of STAAR Surgical, announced it will vote against the company’s proposed $28

Hartman Shareholder Alliance Blasts Silver Star Properties (SLVS) Board for Value Destruction, Urges Return to Proven Leadership

Summary The September 19, 2025 Hartman Shareholder Alliance letter to Silver Star shareholders reiterates that under Hartman’s leadership the